local_hospital
verifiedVerified

MD Korczowski Bartosz Gabinet Lekarski

Address
lock Available on a paid plan

Digestive System Diseases

At MD Korczowski Bartosz Gabinet Lekarski in Rzeszow, much of the research focuses on digestive system diseases, especially inflammatory bowel disease such as Crohn’s disease and ulcerative colitis. These studies are designed to assess new and existing therapies, with attention to symptom control, remission, and long-term treatment benefit in pediatric patients.

  • Testing treatments for Crohn’s disease and ulcerative colitis in children and adolescents
  • Evaluating therapies for complex perianal fistulas and other difficult-to-manage bowel complications
  • Comparing treatment effectiveness for improving clinical remission and digestive health outcomes

The site is also involved in work on gastroesophageal reflux disease, erosive esophagitis, and related upper digestive conditions, broadening its pediatric gastroenterology research portfolio.

Immune System Diseases

Research in immune system diseases at this pediatric center includes studies in Crohn’s disease, ulcerative colitis, and juvenile psoriatic arthritis. The main goal is to better understand how immune-targeted treatments can reduce inflammation and support sustained disease control in young patients.

  • Studying immune-modulating therapies for pediatric inflammatory bowel disease
  • Assessing treatment benefit in juvenile psoriatic arthritis
  • Monitoring long-term safety and effectiveness of biologic therapies

These trials reflect a strong focus on immune-mediated conditions, with research aimed at improving everyday disease management and reducing the burden of chronic inflammation.

Nutritional and Metabolic Diseases

The site also supports studies in nutritional and metabolic diseases, including obesity or overweight and iron deficiency anemia. This work explores new ways to improve metabolic health and address common pediatric nutritional problems that can affect growth, energy, and overall well-being.

  • Evaluating approaches for iron deficiency anemia in children
  • Studying treatment strategies related to obesity and weight-related health concerns
  • Looking at supportive care for children at risk of nutritional deficiency

This area complements the gastroenterology focus by addressing conditions that often overlap with chronic digestive illness and pediatric health challenges.

Skin and Connective Tissue Diseases

Clinical research in skin and connective tissue diseases includes juvenile psoriatic arthritis, a condition that affects both the joints and the immune system. The studies aim to evaluate how well targeted treatments can improve symptoms, function, and long-term disease control in children.

  • Investigating therapies for juvenile psoriatic arthritis
  • Assessing disease control in inflammatory conditions affecting the skin and joints
  • Supporting research on pediatric autoimmune disease

This research adds an important rheumatologic dimension to the site’s pediatric clinical trial activity.

Immune System Processes

A further area of interest is immune system processes, where studies are examining how inflammation develops and how it can be controlled more effectively. At this site, that research is closely tied to chronic intestinal and autoimmune diseases in children.

  • Exploring inflammatory pathways involved in pediatric bowel disease
  • Supporting development of treatments that target immune-driven inflammation
  • Evaluating whether therapies can improve remission and reduce disease activity

Overall, the research profile at MD Korczowski Bartosz Gabinet Lekarski centers on helping children with chronic immune-related conditions through studies of treatment effectiveness, safety, and long-term disease management.

Site Overview

assignment
27
connected trials
corporate_fare
15
sponsors
science
19
IMPs

Activity Indicator

Last 6 months

0
Trials started
-100% vs previous period.
1
Trials started 6–12 months ago
27
Total trials linked
Highly Active
trending_downDeclining-100%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 4 of 6 therapeutic areas and 15 of 19 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
11
Sponsors (total)
15
Active sponsors
9

Sponsor Network

Top 9 by active trials.

lock +8 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +3 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 1 624 other sites in Poland

description
Trial volume
27
Outperforms 90% of sites
public
Therapeutic diversity
6areas
Outperforms 87% of sites
groups
Sponsor diversity
15sponsors
Outperforms 88% of sites

Therapeutic Area Benchmark — Poland

Select a therapeutic area to compare against other sites in Poland.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Poland

Market Share

Country: Poland

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in MD Korczowski Bartosz Gabinet Lekarski

lock Showing 1 of 27 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Phase 2, 2-Part, Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients with Eosinophilic Gastritis with or without Eosinophilic DuodenitisRegeneron Pharmaceuticals Inc.Phase IIRecruitingMar 2024

IMP list

lock Showing 1 of 19 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Vedolizumab4Unknown2018-01-092025-10-15

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.